Medicine guide
mCombriax
·
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Influenza mRNA vaccine;COVID-19 mRNA vaccine
- Made by
- Moderna Biotech Spain, S.L.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- mCombriax is indicated for active immunisation for the prevention of influenza disease and COVID-19 caused by SARS-CoV-2 in individuals 50 years of age and older. The use of this vaccine should be in accordance with official recommendations.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | Moderna Biotech Spain, S.L. |
|---|---|
| Active substance | Influenza mRNA vaccine;COVID-19 mRNA vaccine |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Classification | J07B · Antibiotics, antivirals and antifungals taken into the body |
| Additional monitoring ▼ | Yes — under additional monitoring (black triangle). Report suspected side effects. |
| Authorised on | 2026-04-20 |
| Last updated by the regulator | 2026-09-22 |
| EMA product number | EMEA/H/C/006472 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).